5 results  1 of 1 

1 Patterns and Biologic Features of p53 Mutation Types in Korean Breast Cancer Patients
Hyung Won Kim, Hak Min Lee, Seung Hyun Hwang, Sung Gwe Ahn, Kyung-A Lee, Joon Jeong
J Breast Cancer.2014;17(1):1-7.   Published online 2014 March 28     DOI: http://dx.doi.org/10.4048/jbc.2014.17.1.1
      
2 Expression of Fibroblast Growth Factor Receptor 3 in the Recurrence of Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
Young-Hee Maeng, Su-Yong Eun, Jung-Sik Huh
Korean J Urol.2010;51(2):94-100.   Published online 2010 February 18     DOI: http://dx.doi.org/10.4111/kju.2010.51.2.94
      
3 Clinical Implications of the Expression of Survivin and p53 in Superficial Transitional Cell Carcinoma of the Bladder
Dong Yun Kwak, Ji Yong Ha, Hyuk Soo Chang, Mi Sun Choi, Choal Hee Park, Chun Il Kim
Korean J Urol.2009;50(1):12-17.   Published online 2009 January 31     DOI: http://dx.doi.org/10.4111/kju.2009.50.1.12
      
4 Regulation of p53 Genes by Ferritin Light Chain: Preliminary Study
Sun Young Yi
Ewha Med J.2008;31(1):9-14.   Published online 2008 June 30     DOI: http://dx.doi.org/10.12771/emj.2008.31.1.9
      
5 Clinical Significance of p16 Protein Expression Loss and Aberrant p53 Protein Expression in Pancreatic Cancer
Joon Jeong, Young Nyun Park, Joon Seong Park, Dong-Sup Yoon, Hoon Sang Chi, Byong Ro Kim
Yonsei Med J.2005;46(4):519-525.   Published online 2005 August 31     DOI: http://dx.doi.org/10.3349/ymj.2005.46.4.519
      

 1 of 1